![JBJS.IG.17.01652.ig](https://i0.wp.com/orthobuzz.wpenginepowered.com/wp-content/uploads/2018/09/jbjs-ig-17-01652-ig.png?resize=640%2C360&ssl=1)
Background: Congenital idiopathic clubfoot is a condition that affects, on average, approximately 1 in 1,000 infants. One broadly adopted method of management, described by Ponseti, is the performance of a percutaneous complete tenotomy when hindfoot stall occurs. The use of onabotulinum toxin A (BTX-A) along with the manipulation and cast protocol described by Ponseti has been previously reported. Our goal was to compare the clinical outcomes between BTX-A and placebo injections into the gastrocnemius-soleus muscle at the time of hindfoot stall in infants with idiopathic clubfoot treated with the Ponseti method of manipulation and cast changes.
Like this:
Like Loading...